CELLA, CHIARA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.405
AS - Asia 518
EU - Europa 300
SA - Sud America 119
AF - Africa 12
OC - Oceania 3
Totale 2.357
Nazione #
US - Stati Uniti d'America 1.376
SG - Singapore 220
CN - Cina 106
BR - Brasile 100
HK - Hong Kong 84
UA - Ucraina 54
DE - Germania 44
GB - Regno Unito 38
VN - Vietnam 37
RU - Federazione Russa 30
FI - Finlandia 28
IE - Irlanda 27
TR - Turchia 23
IT - Italia 18
CA - Canada 14
ES - Italia 13
IN - India 13
FR - Francia 12
MX - Messico 12
AR - Argentina 9
PL - Polonia 9
SE - Svezia 9
BD - Bangladesh 8
JP - Giappone 7
ZA - Sudafrica 5
AT - Austria 4
LT - Lituania 4
BE - Belgio 3
EC - Ecuador 3
IQ - Iraq 3
KE - Kenya 3
NL - Olanda 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
ID - Indonesia 2
JO - Giordania 2
PK - Pakistan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
CR - Costa Rica 1
EG - Egitto 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 2.357
Città #
Fairfield 170
Chandler 131
Ashburn 109
Singapore 103
Hong Kong 84
Woodbridge 83
Seattle 76
Houston 75
Wilmington 69
Princeton 54
Cambridge 46
Los Angeles 46
Jacksonville 43
New York 28
Dublin 27
Helsinki 27
Beijing 24
Istanbul 20
Moscow 17
Ann Arbor 16
Ho Chi Minh City 14
Shanghai 14
Buffalo 13
Chicago 13
San Francisco 13
Redondo Beach 12
Dallas 11
London 11
The Dalles 10
Frankfurt am Main 9
Phoenix 9
San Diego 9
Warsaw 9
Chennai 8
Des Moines 8
Rio de Janeiro 8
Stockholm 8
São Paulo 8
Atlanta 7
Mexico City 6
Poplar 6
Santa Clara 6
Tokyo 6
Brooklyn 5
Toronto 5
Boston 4
Düsseldorf 4
Hanoi 4
Orem 4
Amsterdam 3
Ankara 3
Belo Horizonte 3
Brussels 3
Charlotte 3
Dhaka 3
Guangzhou 3
Johannesburg 3
Lauterbourg 3
Montreal 3
Munich 3
Nairobi 3
Portsmouth 3
Querétaro 3
Salvador 3
Amman 2
Aparecida de Goiânia 2
Baghdad 2
Brasília 2
Bắc Ninh 2
Calgary 2
Chongqing 2
Columbus 2
Da Nang 2
Falkenstein 2
Franca 2
Haiphong 2
Hangzhou 2
Ilhéus 2
Kilburn 2
Lahore 2
Manaus 2
Maricá 2
Porto Alegre 2
Quận Bình Thạnh 2
Redwood City 2
Ribeirão Preto 2
Ribeirão das Neves 2
Sabbio Chiese 2
San Jose 2
Santa Fe 2
Santo André 2
Shenyang 2
Tampa 2
Tashkent 2
Tianjin 2
Agudos 1
Andover 1
Annapolis 1
Anyang 1
Araçatuba 1
Totale 1.604
Nome #
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 121
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 120
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis 120
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion of etiopathogenesis and diagnostic tools 102
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside 96
Digital Ischemia in Patients with Solid Tumors: a Case Report and Review of the Literature 95
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? 91
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis 90
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors 87
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 87
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients 86
Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma? 85
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors 85
Treatments for colorectal liver metastases: A new focus on a familiar concept 83
Bevacizumab maintenance in metastatic colorectal cancer: How long? 81
Basaloid squamous cell carcinoma: a rare tumor at the esophagogastric junction and an unexpected durable complete response to FOLFOX-4 79
The Italian Rare Pancreatic Exocrine Cancer Initiative 78
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms 78
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives 77
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? 76
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 75
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 68
High-risk human papillomavirus in anal squamous cell carcinoma: A 'conservative' leading role 68
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 68
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report 66
Cabozantinib in neuroendocrine tumours: tackling drug activity and resistance mechanisms 66
Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials 59
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor 53
The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era 48
Totale 2.388
Categoria #
all - tutte 15.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 17 39 56 57 76 27 34
2021/2022178 0 42 3 11 1 9 15 21 13 6 7 50
2022/2023290 27 0 3 50 14 83 1 32 54 0 9 17
2023/2024156 20 3 11 29 1 10 3 10 34 1 4 30
2024/2025452 0 1 1 67 43 51 48 28 37 46 78 52
2025/2026652 99 116 83 188 147 19 0 0 0 0 0 0
Totale 2.388